🇺🇸 FDA
Patent

US 10603351

Engineered synergistic oncolytic viral symbiosis

granted A61KA61K35/76A61K35/766

Quick answer

US patent 10603351 (Engineered synergistic oncolytic viral symbiosis) held by TURNSTONE LIMITED PARTNERSHIP expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNSTONE LIMITED PARTNERSHIP
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/76, A61K35/766, A61K38/162, A61K38/193